Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy? Cover

.blurhash-client-img { display: none !important; }

Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy?

European Pharmaceutical Journal

Volume 66 (2019): Issue 1 (June 2019)

By: M. Göböová, I. Vaňo, V. Kissová, T. Fazekaš and M. Kuželová

Open Access

|Dec 2019

Authors

M. Göböová

maria.goboova@gmail.com

Department of Internal Medicine, Teaching Hospital Nitra, Nitra

I. Vaňo

Department of Internal Medicine, Teaching Hospital Nitra, Nitra

V. Kissová

Department of Internal Medicine, Teaching Hospital Nitra, Nitra

T. Fazekaš

Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University, Bratislava

M. Kuželová

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava

DOI: https://doi.org/10.2478/afpuc-2019-0002 | Journal eISSN: 2453-6725

Journal RSS Feed

Language: English

Page range: 11 - 18

Submitted on: Sep 24, 2018

Accepted on: Jan 11, 2019

Published on: Dec 26, 2019

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

therapeutic drug monitoring,

adjustment of dosage of gentamicin

Related subjects:

Pharmacy, other

© 2019 M. Göböová, I. Vaňo, V. Kissová, T. Fazekaš, M. Kuželová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 66 (2019): Issue 1 (June 2019)Next article